Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Angiotensin receptor blockers (ARBs) are commonly used as a treatment for many cardiovascular diseases, but their safety has been called into question. The VALUE trial found an increased risk of myocardial infarction in participants receiving ARBs compared to other antihypertensive. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanas, Yara, Bashir, Rim, Islam, Nazmul, Furuya-Kanamori, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175553/
https://www.ncbi.nlm.nih.gov/pubmed/32316917
http://dx.doi.org/10.1186/s12872-020-01466-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175553/
https://www.ncbi.nlm.nih.gov/pubmed/32316917
http://dx.doi.org/10.1186/s12872-020-01466-5

Ejemplares similares